|
|
|
 |
FDA Approval Activities for this Drug…
Alphagan (brimonidine tartrate ophthalmic solution), 0.5, 0.2 & (P) 0.15%, Allergan NDA 20-490/S7, 20-613/S18 & 21-262/S6 12/20/01 6/19/02 6/19/02 6/19/02 Alphagan P (brimonidine tartrate ophthalmic solution), 0.15%, Allergan NDA 21-262 Brimonidine Tartrate Ophthalmic Solution, 0.2%, Bausch & Lomb ANDA 76-260 5/28/03 Brimonidine Tartrate Ophthalmic Solution, 0.2%, Alcon ANDA 76-254 9/16/03 Brimonidine Tartrate Ophthalmic Solution, 0.2%, Alcon Universal, Ltd. ANDA 76-254 Brimonidine Tartrate Ophthalmic Solution, Ivax Pharma, Approval | Alphagan P (brimonidine tartrate) ophthalmic solution, Allergan, , Approval | Alphagan P (brimonidine tartrate ophthalmic solution), Allergan, Labeling Revision | Alphagan P (brimonidine tartrate ophthalmic solution), Allergan, Inc., Labeling Revision | Brimonidine Tartrate Ophthalmic Solution, Alcon, Inc., Approval | COMBIGAN (brimonidine tartrate/timolol maleate) Ophthalmic Solution, Allergan Inc., Approval | Brimonidine Tartrate Ophthalmic Solution, Sandoz Inc., Approval | Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, Alcon Research, Ltd., Tentative Approval | Brimonidine Tartrate Ophthalmic Solution, Alcon Research, Ltd., Labeling Revision | Alphagan P (brimonidine tartrate) Ophthalmic Solution, Allergan, Inc., Labeling Revision | Alphagan P (brimonidine tartrate) Ophthalmic Solution, Allergan, Inc., Labeling Revision | Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, Hi-Tech Pharmacal Co., Inc., Tentative Approval | Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, Sandoz, Inc., Tentative Approval
  
|